期刊文献+

Ⅰ期肺癌患者术后复发的影响因素分析

Influencing factors of postoperative recurrence in patients with stage Ⅰ lung cancer
下载PDF
导出
摘要 目的分析Ⅰ期肺癌患者术后复发的影响因素。方法回顾性收集2016—2018年邯郸市中心医院收治的147例行肺癌根治术的Ⅰ期肺癌患者的临床资料。电话随访2年,统计患者术后复发情况,记录患者1、2年累积生存率。采用多因素Logistic回归分析Ⅰ期肺癌患者术后复发的影响因素。结果147例患者中,复发19例,复发率为12.9%;1年累积生存率为95.2%,2年累积生存率为88.4%。单因素分析结果显示,不同分化程度、肿瘤最大直径、清扫淋巴结数目及有无肺膜转移、吸烟史、毛刺征象的患者术后复发率比较,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,有肺膜转移、有毛刺征象是Ⅰ期肺癌患者术后复发的独立危险因素,低分化、肿瘤最大直径≤2.5 mm、清扫淋巴结数目≥12个是其术后复发的保护因素(P<0.05)。结论有肺膜转移、毛刺征象是Ⅰ期肺癌患者术后复发的独立危险因素,低分化、肿瘤最大直径≤2.5 mm、清扫淋巴结数目≥12个是其术后复发的保护因素。 Objective To analyze the influencing factors of postoperative recurrence in patients with stage Ⅰ lung cancer. Methods The clinical data of 147 patients with stage Ⅰ lung cancer received in Handan Central Hospital from 2016to 2018 were retrospectively collected. Following-up for 2 years by telephone,incidence of postoperative recurrence was counted,and the cumulative survival rate was recorded. Multivariate Logistic regression analysis was used to analyze the influencing factors of postoperative recurrence of stage Ⅰ lung cancer patients. Results There were 19 cases of recurrence in147 patients,the recurrence rate was 12. 9%. The 1-year cumulative survival rate was 95. 2% and the 2-year cumulative survival rate was 88. 4%. Multivariate Logistic regression analysis showed that pulmonary membrane metastasis,burr sign were risk factors of postoperative recurrence of stage Ⅰ lung cancer patients,poorly differentiated,maximum diameter of tumor≤2. 5 mm,number of lymph nodes cleaned≥12 were protective factors of postoperative recurrence of stage Ⅰ lung cancer patients( P < 0. 05). Conclusion Pulmonary membrane metastasis,burr sign are risk factors of postoperative recurrence of stage Ⅰ lung cancer patients,poorly differentiated,maximum diameter of tumor≤2. 5 mm,number of lymph nodes cleaned≥12 are protective factors of postoperative recurrence of stage Ⅰ lung cancer patients.
作者 冀青青 贾亚波 田遂 杨模 刘峥 JI Qingqing;JIA Yabo;TIAN Sui;YANG Mo;LIU Zheng(Hebei North University,Zhangjiakou 075000,China;不详)
出处 《临床合理用药杂志》 2022年第21期30-32,36,共4页 Chinese Journal of Clinical Rational Drug Use
关键词 肺癌 肿瘤分期 复发 转移 影响因素分析 Lung cancer Staging Recurrence Metastatic Root cause analysis
  • 相关文献

参考文献4

二级参考文献43

  • 1Aberle DR,Adams AM,Berg CD,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine . 2011
  • 2Patz EF Jr,Caporaso NE,Dubinett SM,et al.National lung cancer screening trial american college of radiology imaging network specimen biorepository originating from the contemporary screening for the detection of Lung cancer trial (NLST,ACRIN6654) design,intent,and availability of specimens for v. J Thorac Oncol . 2010
  • 3Steinert HC.PET and PET-CT of lung cancer. Methods in Molecular Biology . 2011
  • 4Ashraf H,Dirksen A,Loft A,et al.Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning. Thorax . 2011
  • 5Khoo KL,Ho KY.Endoscopic mediastinal staging of lung cancer. Respiratory Medicine . 2011
  • 6Neumann H,Fuchs FS,Vieth M,et al.Review article:in vivo imaging by endocytoscopy. Alimentary Pharmacology and Therapeutics . 2011
  • 7Shibuya K,Fujiwara T,Yasufuku K,et al.In vivo microscopic imaging of the bronchial mucosa using an endo-cytoscopy system. Lung Cancer . 2011
  • 8Neumann H,Vieth M,Neurath MF,et al.In vivo diagnosis of small-cell lung cancer by endocytoscopy. Journal of Clinical Oncology . 2011
  • 9Bajtarevic A,Ager C,Pienz M,et al.Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer . 2009
  • 10Doria-Rose VP,Marcus PM,Szabo E,et al.Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited:a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer . 2009

共引文献4102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部